Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 14623619)

1.

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

El-Serag HB, Davila JA, Petersen NJ, McGlynn KA.

Ann Intern Med. 2003 Nov 18;139(10):817-23. Erratum in: Ann Intern Med. 2004 Jan 20;140(2):151.

PMID:
14623619
2.

Geographic variation within the United States in the incidence of hepatocellular carcinoma.

Davila JA, Petersena NJ, Nelson HA, El-Serag HB.

J Clin Epidemiol. 2003 May;56(5):487-93.

PMID:
12812824
3.

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.

Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB.

Gastroenterology. 2004 Nov;127(5):1372-80.

PMID:
15521006
4.

Summaries for patients. Increasing rates of primary liver cancer in the United States.

[No authors listed]

Ann Intern Med. 2003 Nov 18;139(10):I28. No abstract available.

PMID:
14623640
5.
6.

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.

McGlynn KA, Tarone RE, El-Serag HB.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203.

7.

Racial and ethnic variations in hepatocellular carcinoma incidence within the United States.

Wong R, Corley DA.

Am J Med. 2008 Jun;121(6):525-31. doi: 10.1016/j.amjmed.2008.03.005.

PMID:
18501235
8.

Rising incidence of hepatocellular carcinoma in the United States.

El-Serag HB, Mason AC.

N Engl J Med. 1999 Mar 11;340(10):745-50.

9.

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP.

Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.

10.

Epidemiology of hepatocellular carcinoma.

el-Serag HB.

Clin Liver Dis. 2001 Feb;5(1):87-107, vi. Review.

PMID:
11218921
11.

Hepatocellular carcinoma: recent trends in the United States.

El-Serag HB.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. Review.

PMID:
15508094
12.

Epidemiology of hepatocellular carcinoma in Hispanics in the United States.

El-Serag HB, Lau M, Eschbach K, Davila J, Goodwin J.

Arch Intern Med. 2007 Oct 8;167(18):1983-9.

PMID:
17923599
13.

Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study.

Blake PW, Bradford PT, Devesa SS, Toro JR.

Arch Dermatol. 2010 Jun;146(6):625-32. doi: 10.1001/archdermatol.2010.105.

PMID:
20566926
14.

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Altekruse SF, McGlynn KA, Reichman ME.

J Clin Oncol. 2009 Mar 20;27(9):1485-91. doi: 10.1200/JCO.2008.20.7753. Epub 2009 Feb 17.

15.

Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program.

Wichajarn K, Kosalaraksa P, Wiangnon S.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):507-9.

16.

Risk factors for the rising rates of primary liver cancer in the United States.

El-Serag HB, Mason AC.

Arch Intern Med. 2000 Nov 27;160(21):3227-30.

PMID:
11088082
17.

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

Shaib YH, Davila JA, McGlynn K, El-Serag HB.

J Hepatol. 2004 Mar;40(3):472-7.

PMID:
15123362
18.

Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century.

Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F; EUROCARE Working Group.

Am J Gastroenterol. 2007 Aug;102(8):1661-70; quiz 1660, 1671. Epub 2007 Jun 6.

PMID:
17555459
19.

The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States.

Kulkarni K, Barcak E, El-Serag H, Goodgame R.

Aliment Pharmacol Ther. 2004 Aug 15;20(4):445-50.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk